Two Shares Face To Face: Southern Company (The) (NYSE:SO), ResMed Inc. (NYSE:RMD)

Southern Company (The) (NYSE:SO)

Southern Company (The) (NYSE:SO) closed at $68.12 on the last trading session with an increase of 1.28%, whereas, it previously closed at $67.26. The company has a market capitalization of $71.39 Billion. The company traded shares of 3.78 Million on the trading day while its three month average volume stands at 4.52 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Southern Company (The) (NYSE:SO) produced diluted EPS of 4.33. The EPS estimate for next year as estimated by analysts is at 3.18 while EPS for next quarter is estimated at 0.29. Earnings per Share growth for this year is reported at 273.6, while the analysts estimated the EPS growth for next year at 3.18% and Earnings growth for next 5 years stands at 1.53% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 2.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Southern Company (The) (NYSE:SO) is at 15.72 while the forward p/e is at 21.44. The P/S or Price to Sales ratio of Southern Company (The) (NYSE:SO) stands at 3.27 and Price to Book or P/B for the most recent quarter stands at 2.6. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Southern Company (The) (NYSE:SO) are reported at 0.7 and 0.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Southern Company (The) (NYSE:SO) stands at 4, 17.3 and 5.2 respectively

The trailing twelve month Revenue of Southern Company (The) (NYSE:SO) is reported at 21.84 Billion with income of 4.55 Billion. The outstanding shares of Southern Company (The) (NYSE:SO) are 1.05 Billion. The institutional Ownership of the shares of 60.9 stands at 0.80%, this figure is increased 0.04 in the last six months. The insider ownership for the shares of Southern Company (The) (NYSE:SO) is ticked at 0.1%, the figure is plummeted -71.22% in the last six months.

Some other important financial aspects to be discussed here for Southern Company (The) (NYSE:SO) is the Mean Target Price estimated by the analysts which stands at 62.81. The 52 week high of Southern Company (The) (NYSE:SO) is placed at 67.33 and 52 week low is standing at 46.49.

Performance wise the shares of Southern Company (The) (NYSE:SO) rose up 5.55% for the week, it also rise 7.06% for the monthly performance, while for the quarter it went down 11.42%. The shares increase 22.78% for the half year and flew up for the Year-To-Date performance. The shares of Southern Company (The) (NYSE:SO) grew 44.26% for the yearly performance.

ResMed Inc. (NYSE:RMD)

ResMed Inc. (NYSE:RMD) closed at $161.94 on the last trading session with an increase of 0.85%, whereas, it previously closed at $160.57. The company has a market capitalization of $23.27 Billion. The company traded shares of 506254 on the trading day while its three month average volume stands at 507.85 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of ResMed Inc. (NYSE:RMD) produced diluted EPS of 2.94. The EPS estimate for next year as estimated by analysts is at 4.51 while EPS for next quarter is estimated at 1.03. Earnings per Share growth for this year is reported at -9.6, while the analysts estimated the EPS growth for next year at 4.51% and Earnings growth for next 5 years stands at 20.9% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 3.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of ResMed Inc. (NYSE:RMD) is at 55.1 while the forward p/e is at 35.88. The P/S or Price to Sales ratio of ResMed Inc. (NYSE:RMD) stands at 8.62 and Price to Book or P/B for the most recent quarter stands at 10.99. The Price to Free Cash Flow ratio or P/FCF is reported at 83.15. The quick ratio and the current ratio of ResMed Inc. (NYSE:RMD) are reported at 1.5 and 2.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for ResMed Inc. (NYSE:RMD) stands at 10.3, 20.5 and 13.7 respectively

The trailing twelve month Revenue of ResMed Inc. (NYSE:RMD) is reported at 2.7 Billion with income of 425.1 Million. The outstanding shares of ResMed Inc. (NYSE:RMD) are 143.72 Million. The institutional Ownership of the shares of 70.8 stands at 0.80%, this figure is increased 0.04 in the last six months. The insider ownership for the shares of ResMed Inc. (NYSE:RMD) is ticked at 0.8%, the figure is plummeted -13.54% in the last six months.

Some other important financial aspects to be discussed here for ResMed Inc. (NYSE:RMD) is the Mean Target Price estimated by the analysts which stands at 142. The 52 week high of ResMed Inc. (NYSE:RMD) is placed at 161.98 and 52 week low is standing at 90.64.

Performance wise the shares of ResMed Inc. (NYSE:RMD) rose up 2.32% for the week, it also rise 3.79% for the monthly performance, while for the quarter it went down 23.42%. The shares increase 30.98% for the half year and flew up for the Year-To-Date performance. The shares of ResMed Inc. (NYSE:RMD) grew 37.42% for the yearly performance.